Literature DB >> 23275339

Peroxisome proliferator-activated receptor γ agonists induce cell cycle arrest through transcriptional regulation of Kruppel-like factor 4 (KLF4).

Sheng Li1, Qibing Zhou, Huan He, Yahui Zhao, Zhihua Liu.   

Abstract

Peroxisome proliferator-activated receptor γ (PPARγ), a subgroup of ligand-activated nuclear receptors, plays critical roles in cell cycle regulation, differentiation, apoptosis, and invasion. PPARγ is involved in tumorigenesis and is a potent target for cancer therapy. PPARγ transactivation of KLF4 has been demonstrated in various studies; however, how PPARγ regulates KLF4 expression is not clear. In this study, we reveal that PPARγ regulates the expression of KLF4 by binding directly to the PPAR response element (PPRE) within the KLF4 promoter. The PPRE resides at -1657 to -1669 bp upstream of the KLF4 ATG codon, which is essential for the transactivation of troglitazone-induced KLF4 expression. Furthermore, we found that stable silencing of KLF4 obviously suppressed the G(1)/S arrest and anti-proliferation effects induced by PPARγ ligands. Taken together, our data indicate that up-regulation of KLF4 upon PPARγ activation is mediated through the PPRE in the KLF4 promoter, thus providing further insights into the PPARγ signal transduction pathway as well as a novel cancer therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23275339      PMCID: PMC3567659          DOI: 10.1074/jbc.M111.317487

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  The many faces of PPARgamma.

Authors:  Michael Lehrke; Mitchell A Lazar
Journal:  Cell       Date:  2005-12-16       Impact factor: 41.582

2.  Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF.

Authors:  K W Foster; S Ren; I D Louro; S M Lobo-Ruppert; P McKie-Bell; W Grizzle; M R Hayes; T R Broker; L T Chow; J M Ruppert
Journal:  Cell Growth Differ       Date:  1999-06

Review 3.  Emerging role of KLF4 in human gastrointestinal cancer.

Authors:  Daoyan Wei; Masashi Kanai; Suyun Huang; Keping Xie
Journal:  Carcinogenesis       Date:  2005-10-11       Impact factor: 4.944

4.  Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells.

Authors:  N Takahashi; T Okumura; W Motomura; Y Fujimoto; I Kawabata; Y Kohgo
Journal:  FEBS Lett       Date:  1999-07-16       Impact factor: 4.124

5.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene.

Authors:  Benjamin D Rowland; René Bernards; Daniel S Peeper
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

Review 6.  Medical significance of peroxisome proliferator-activated receptors.

Authors:  J Vamecq; N Latruffe
Journal:  Lancet       Date:  1999-07-10       Impact factor: 79.321

7.  Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

Authors:  P Tontonoz; S Singer; B M Forman; P Sarraf; J A Fletcher; C D Fletcher; R P Brun; E Mueller; S Altiok; H Oppenheim; R M Evans; B M Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

8.  15-deoxy-Delta12,14 prostaglandin J2 up-regulates Kruppel-like factor 4 expression independently of peroxisome proliferator-activated receptor gamma by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells.

Authors:  Zhi Yi Chen; Chi-Chuan Tseng
Journal:  Mol Pharmacol       Date:  2005-08-02       Impact factor: 4.436

9.  Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

Authors:  T Kubota; K Koshizuka; E A Williamson; H Asou; J W Said; S Holden; I Miyoshi; H P Koeffler
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

10.  Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages.

Authors:  G Chinetti; S Griglio; M Antonucci; I P Torra; P Delerive; Z Majd; J C Fruchart; J Chapman; J Najib; B Staels
Journal:  J Biol Chem       Date:  1998-10-02       Impact factor: 5.157

View more
  13 in total

1.  Ethanol-induced changes in poly (ADP ribose) polymerase and neuronal developmental gene expression.

Authors:  David P Gavin; Handojo Kusumo; Rajiv P Sharma; Marina Guizzetti
Journal:  Neuropharmacology       Date:  2016-08-04       Impact factor: 5.250

2.  Krüppel-like Factor 4 Promotes Esophageal Squamous Cell Carcinoma Differentiation by Up-regulating Keratin 13 Expression.

Authors:  Huan He; Sheng Li; Yuan Hong; Haojing Zou; Hongyan Chen; Fang Ding; Yong Wan; Zhihua Liu
Journal:  J Biol Chem       Date:  2015-04-07       Impact factor: 5.157

3.  Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.

Authors:  Yahui Zhao; Aiping Luo; Sheng Li; Wei Zhang; Hongyan Chen; Yi Li; Fang Ding; Furong Huang; Zhihua Liu
Journal:  J Biol Chem       Date:  2016-02-08       Impact factor: 5.157

4.  12-O-tetradecanoylphorbol-13-acetate promotes breast cancer cell motility by increasing S100A14 level in a Kruppel-like transcription factor 4 (KLF4)-dependent manner.

Authors:  Huan He; Sheng Li; Hongyan Chen; Lin Li; Chengshan Xu; Fang Ding; Yun Zhan; Jianlin Ma; Shuguang Zhang; Yaoting Shi; Chunfeng Qu; Zhihua Liu
Journal:  J Biol Chem       Date:  2014-02-14       Impact factor: 5.157

5.  Coffee component hydroxyl hydroquinone (HHQ) as a putative ligand for PPAR gamma and implications in breast cancer.

Authors:  Babita Shashni; Karun Sharma; Rumani Singh; Kishore R Sakharkar; Sarinder K Dhillon; Yukio Nagasaki; Meena K Sakharkar
Journal:  BMC Genomics       Date:  2013-10-16       Impact factor: 3.969

6.  Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth.

Authors:  Swei Sunny Hann; Qing Tang; Fang Zheng; Shunyu Zhao; Jianping Chen; ZhiYu Wang
Journal:  Mol Cancer       Date:  2014-06-13       Impact factor: 27.401

7.  Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma.

Authors:  Hui-Tzu Hsu; Ming-Ta Sung; Chih-Chun Lee; Yin-Ju Kuo; Chin-Wen Chi; Hsin-Chen Lee; Cheng-Yuan Hsia
Journal:  Int J Mol Sci       Date:  2016-07-29       Impact factor: 5.923

8.  Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles.

Authors:  Ting Yan; Akifumi Mizutani; Ling Chen; Mai Takaki; Yuki Hiramoto; Shuichi Matsuda; Tsukasa Shigehiro; Tomonari Kasai; Takayuki Kudoh; Hiroshi Murakami; Junko Masuda; Mary J C Hendrix; Luigi Strizzi; David S Salomon; Li Fu; Masaharu Seno
Journal:  J Cancer       Date:  2014-07-05       Impact factor: 4.207

9.  Drug target prioritization by perturbed gene expression and network information.

Authors:  Zerrin Isik; Christoph Baldow; Carlo Vittorio Cannistraci; Michael Schroeder
Journal:  Sci Rep       Date:  2015-11-30       Impact factor: 4.379

10.  MicroRNA-130b promotes lung cancer progression via PPARγ/VEGF-A/BCL-2-mediated suppression of apoptosis.

Authors:  Jianwei Tian; Liping Hu; Xiao Li; Jian Geng; Meng Dai; Xiaoyan Bai
Journal:  J Exp Clin Cancer Res       Date:  2016-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.